C
Enterprise AI and real-world data SaaS solutions for life sciences and healthcare clinical research.
About
ConcertAI offers generative and agentic AI solutions tailored for life sciences and healthcare products, focusing on regulatory, research, commercial, and clinical development needs. Their platform leverages real-world data to provide precision insights, accelerate clinical trials, and support regulatory-grade evidence and commercial outcomes. Key offerings include the Precision Suite, Commercial Solutions, Clinical Development tools, CancerLinQ, and TeraRecon for advanced medical imaging.
Pricing
View pricing page ↗Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
69Traction
40Team
30Visibility
2Profile
0Community
17Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does ConcertAI do?
ConcertAI offers generative and agentic AI solutions tailored for life sciences and healthcare products, focusing on regulatory, research, commercial, and clinical development needs. Their platform leverages real-world data to provide precision insights, accelerate clinical trials, and support regulatory-grade evidence and commercial outcomes. Key offerings include the Precision Suite, Commercial Solutions, Clinical Development tools, CancerLinQ, and TeraRecon for advanced medical imaging.
How much funding has ConcertAI raised?
ConcertAI has raised a total of $300M in funding. The most recent round on record is Series C.
Where is ConcertAI headquartered?
ConcertAI is headquartered in Cambridge, United States.
When was ConcertAI founded?
ConcertAI was founded in 2018.
What industry does ConcertAI operate in?
ConcertAI operates in AI, SaaS, HealthTech, Life Sciences, Agentic AI.